List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market 24
Figure 7. World Pharmaceutical CDMO Market, 2019-2030, $ bn 27
Figure 8. World Drug Discovery Market, 2019-2030, $ mn 27
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market 36
Figure 12. Breakdown of Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, % of Revenue 41
Figure 13. Asia Pacific Addressable Market Cap in 2022-2031 by Service Type, Value ($ mn) and Share (%) 41
Figure 14. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Bioanalytical Testing, 2021-2031, $ mn 42
Figure 15. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Bioanalytical Testing: Clinical Testing, 2021-2031, $ mn 43
Figure 16. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Bioanalytical Testing: Non-clinical Testing, 2021-2031, $ mn 44
Figure 17. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Method Development and Validation, 2021-2031, $ mn 45
Figure 18. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Extractable & Leachable, 2021-2031, $ mn 47
Figure 19. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Impurity Method, 2021-2031, $ mn 48
Figure 20. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Technical Consulting, 2021-2031, $ mn 49
Figure 21. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Other Methods, 2021-2031, $ mn 50
Figure 22. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Stability Testing, 2021-2031, $ mn 51
Figure 23. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Drug Substances Testing , 2021-2031, $ mn 53
Figure 24. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Accelerated Stability Testing, 2021-2031, $ mn 54
Figure 25. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Photostability Testing, 2021-2031, $ mn 55
Figure 26. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Other Stability Testings, 2021-2031, $ mn 56
Figure 27. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Other Services, 2021-2031, $ mn 57
Figure 28. Breakdown of Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Product Type, 2021-2031, % of Sales Revenue 59
Figure 29. Asia Pacific Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 59
Figure 30. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Product Type: Raw Materials & Additives, 2021-2031, $ mn 60
Figure 31. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Product Type: Active Pharmaceutical Ingredients (APIs), 2021-2031, $ mn 61
Figure 32. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Product Type: Finished Products, 2021-2031, $ mn 62
Figure 33. Breakdown of Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, % of Sales Revenue 64
Figure 34. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 64
Figure 35. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by End User: Pharmaceutical & Biopharmaceutical Companies, 2021-2031, $ mn 65
Figure 36. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by End User: Contract Manufacturing Organizations (CMOs), 2021-2031, $ mn 66
Figure 37. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by End User: Other End Users, 2021-2031, $ mn 67
Figure 38. Breakdown of Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, % of Revenue 69
Figure 39. Asia Pacific Addressable Market Cap in 2022-2031 by Organization Size, Value ($ mn) and Share (%) 69
Figure 40. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Organization Size: SMEs, 2021-2031, $ mn 70
Figure 41. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market by Organization Size: Large Enterprises, 2021-2031, $ mn 71
Figure 42. Breakdown of APAC Pharmaceutical Analytical Testing Outsourcing Market by Country, 2021 and 2031, % of Revenue 73
Figure 43. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 74
Figure 44. Pharmaceutical Analytical Testing Outsourcing Market in Japan, 2021-2031, $ mn 76
Figure 45. Pharmaceutical Analytical Testing Outsourcing Market in China, 2021-2031, $ mn 79
Figure 46. Pharmaceutical Analytical Testing Outsourcing Market in Australia, 2021-2031, $ mn 81
Figure 47. Pharmaceutical Analytical Testing Outsourcing Market in India, 2021-2031, $ mn 83
Figure 48. Pharmaceutical Analytical Testing Outsourcing Market in South Korea, 2021-2031, $ mn 85
Figure 49. Pharmaceutical Analytical Testing Outsourcing Market in Rest of APAC, 2021-2031, $ mn 87
Figure 50. Growth Stage of Asia Pacific Pharmaceutical Analytical Testing Outsourcing Industry over the Forecast Period 89
Asia Pacific pharmaceutical analytical testing outsourcing market will grow by 10.2% annually with a total addressable market cap of $30,233.3 million over 2022-2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities. Highlighted with 31 tables and 50 figures, this 108-page report “Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Others), Product Type (Raw Materials & Additives, APIs, Finished Products), End User (Pharma & Biopharma Companies, CMOs, Others), Organization Size (SMEs, Large Enterprises), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific pharmaceutical analytical testing outsourcing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific pharmaceutical analytical testing outsourcing market in every aspect of the classification from perspectives of Service Type, Product Type, End User, Organization Size, and Country. Based on Service Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Bioanalytical Testing o Clinical Testing o Non-clinical Testing • Method Development and Validation o Extractable & Leachable o Impurity Method o Technical Consulting o Other Methods • Stability Testing o Drug Substances Testing o Accelerated Stability Testing o Photostability Testing o Other Stability Testings • Other Services Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Raw Materials & Additives • Active Pharmaceutical Ingredients (APIs) • Finished Products By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharmaceutical & Biopharmaceutical Companies • Contract Manufacturing Organizations (CMOs) • Other End Users By Organization Size, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • SMEs • Large Enterprises Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Service Type, End User and Organization Size over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Boston Analytical, Inc. Charles River Laboratories International, Inc. Eurofins Scientific SE Exova Group PLC Intertek Pharmaceutical Services Laboratory Testing Inc. Pace Analytical Services LLC Pharmaceutical Product Development, LLC SGS SA Steris PLC Tentamus Toxikon Inc. West Pharmaceutical Services Inc. WuXi AppTec, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More